MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare.
MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US.
MedGenome Inc. offers Next-Generation Sequencing based genomic solutions in cancer immunotherapy and metabolic diseases. Its unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level, to facilitate research in personalized health care.
MedGenome Labs is the market leader for genetic diagnostic testing in India and South Asia, applying Next Generation Sequencing (NGS) techniques to large disease cohorts in cancer, eye and neurological disorders, diabetes, cardiovascular diseases and rare cancers.